Xylem Inc
NYSE:XYL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
102.86
152.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
XYL
stock under the Base Case scenario is
128.81
USD.
Compared to the current market price of 137.04 USD,
Xylem Inc
is
Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Xylem Inc.
| JP |
I
|
Ishii Iron Works Co Ltd
TSE:6362
|
|
| US |
|
Parker-Hannifin Corp
NYSE:PH
|
|
| JP |
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
|
| SE |
|
Atlas Copco AB
STO:ATCO A
|
|
| US |
|
Illinois Tool Works Inc
NYSE:ITW
|
|
| US |
|
Barnes Group Inc
NYSE:B
|
|
| SE |
|
Sandvik AB
STO:SAND
|
|
| CH |
|
Schindler Holding AG
SIX:SCHP
|
|
| JP |
|
Fanuc Corp
TSE:6954
|
|
| FI |
K
|
Kone Oyj
OMXH:KNEBV
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
The integration of Evoqua Water Technologies adds operational complexity and could dilute margins if expected cost synergies and cross-selling opportunities are not realized as planned.
Municipal budget constraints, driven by market cycles or tighter government spending, could slow the adoption of Xylem’s large-scale water infrastructure projects, undermining revenue growth estimates.
Competition from established industrial conglomerates and emerging water-tech startups threatens Xylem’s market share in sensor-based treatment systems and advanced analytics, potentially forcing costly R&D outlays.
Xylem’s leadership in water solutions and recent Evoqua acquisition positions the company to capture higher market share in advanced treatment technologies, especially as global water scarcity concerns escalate.
The company’s increasing emphasis on digital solutions, such as smart notifications and AI-driven monitoring, can drive premium pricing and customer loyalty, supporting long-term profitability.
Its diversified worldwide presence and exposure to both industrial and municipal segments help mitigate demand downturns in any single market, stabilizing overall revenue growth.
Revenue & Expenses Breakdown
Xylem Inc
Balance Sheet Decomposition
Xylem Inc
| Current Assets | 4.4B |
| Cash & Short-Term Investments | 1.2B |
| Receivables | 1.8B |
| Other Current Assets | 1.4B |
| Non-Current Assets | 12.9B |
| PP&E | 1.1B |
| Intangibles | 10.6B |
| Other Non-Current Assets | 1.1B |
| Current Liabilities | 2.3B |
| Accounts Payable | 968m |
| Accrued Liabilities | 635m |
| Other Current Liabilities | 666m |
| Non-Current Liabilities | 3.8B |
| Long-Term Debt | 1.9B |
| Other Non-Current Liabilities | 1.9B |
Free Cash Flow Analysis
Xylem Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Xylem Inc
|
Revenue
|
8.9B
USD
|
|
Cost of Revenue
|
-5.5B
USD
|
|
Gross Profit
|
3.4B
USD
|
|
Operating Expenses
|
-2.2B
USD
|
|
Operating Income
|
1.2B
USD
|
|
Other Expenses
|
-284m
USD
|
|
Net Income
|
948m
USD
|
XYL Profitability Score
Profitability Due Diligence
Xylem Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Xylem Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
XYL Solvency Score
Solvency Due Diligence
Xylem Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
Xylem Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XYL Price Targets Summary
Xylem Inc
According to Wall Street analysts, the average 1-year price target for
XYL
is 171.31 USD
with a low forecast of 128.5 USD and a high forecast of 191.1 USD.
Dividends
Current shareholder yield for
XYL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
XYL
stock under the Base Case scenario is
128.81
USD.
Compared to the current market price of 137.04 USD,
Xylem Inc
is
Overvalued by 6%.